Company

Practical CNS medicines through disciplined science.

Telesti exists to develop CNS medicines that are both scientifically differentiated and practical to deliver.

Austin-based. Stage-gated. Built around intellectual honesty, reproducibility, capital efficiency and clear decisions.
Mission

Ambitious therapeutic design. Explicit decision standards.

We combine medicinal chemistry and CNS development strategy with an operating model that asks a simple question at every stage: what evidence is required to advance, redesign or stop?

This approach is intended to preserve scientific ambition while preventing weak assumptions from compounding into expensive development commitments.

Operating philosophy

Four commitments.

01
Intellectual honesty

Distinguish hypotheses, evidence and human validation.

02
Reproducibility

Trace material claims to controlled data and independent confirmation.

03
Capital efficiency

Fund to objective checkpoints with protected contingency.

04
Patient-relevant design

Evaluate practical delivery and safety alongside mechanism.

Founders

Chemistry and execution.

Portrait of Uroš Laban

Uroš Laban, PhD

Co-founder & Chief Scientific Officer

Uroš leads medicinal chemistry and scientific strategy. His background includes CNS drug discovery, structure–activity relationship development and the design of next-generation serotonergic compounds.

Portrait of Graham Pilger

Graham Pilger

Co-founder & Chief Executive Officer

Graham leads company strategy, financing, partnerships and program execution. His background spans psychiatry research, early-stage healthcare ventures and operational leadership across emerging therapeutic modalities.

Biographies and credentials should receive final individual and company approval before production launch.

Austin, Texas

Built in a growing life-sciences and technology ecosystem.

Telesti operates from Austin and works with a distributed network of scientific, regulatory, legal and development collaborators.

Advisors and collaborators are named publicly only after written consent and verification of titles and affiliations.

Careers & collaboration

Exceptional scientists and operators are welcome.

We welcome targeted expressions of interest from people aligned with rigorous CNS development and stage-gated execution.